UB Paderborn / Katalog / Suche / in CDI

Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine

European Journal of Nuclear Medicine, 1994-07, Vol.21 (7), p.663-665

1994

Link zum Volltext

Verfügbarkeit prüfen

Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates

Bioconjugate chemistry, 1993-01, Vol.4 (1), p.25-33

1993

Link zum Volltext

Verfügbarkeit prüfen

Circulating antigen: Bad or good for immunoscintigraphy?

Nuclear medicine and biology, 1995-02, Vol.22 (2), p.137-145

Pimm, Malcolm V.

1995

Link zum Volltext

Verfügbarkeit prüfen

An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts

British journal of cancer, 1990-07, Vol.62 (1), p.69-71

PIMM, M. V

1990

Link zum Volltext

Verfügbarkeit prüfen

Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments

Anticancer research, 1993-01, Vol.13 (1), p.241

1993

Link zum Volltext

Verfügbarkeit prüfen

Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone

Bioconjugate chemistry, 1990-11, Vol.1 (6), p.425-430

1990

Link zum Volltext

Verfügbarkeit prüfen

The Characteristics of Blood-Borne Radiolabels and the Effect of Anti-Mouse IgG Antibodies on Localization of Radiolabeled Monoclonal Antibody in Cancer Patients

The Journal of nuclear medicine (1978), 1985-09, Vol.26 (9), p.1011-1023

1985

Link zum Volltext

Verfügbarkeit prüfen

Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations

Critical reviews in therapeutic drug carrier systems, 1988, Vol.5 (3), p.189

Pimm, M V

1988

Link zum Volltext

Verfügbarkeit prüfen

Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope

Nuclear medicine communications, 1993-07, Vol.14 (7), p.578-586

1993

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of monoclonal idiotypic-specific antibodies as clearing antibodies for enhancement of target localisation by tumour-specific monoclonal antibodies: diversity of effects in nude mice with human tumour xenografts

European Journal of Nuclear Medicine, 1992-06, Vol.19 (6), p.436

1992

Link zum Volltext

Verfügbarkeit prüfen

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate

British journal of cancer, 1990-04, Vol.61 (4), p.508-513

1990

Link zum Volltext

Verfügbarkeit prüfen

Carrier Design: New Generation of Polycationic Branched Polypeptides Containing OH Groups with Prolonged Blood Survival and Diminished in Vitro Cytotoxicity

Bioconjugate chemistry, 1999-09, Vol.10 (5), p.781-790

1999

Link zum Volltext

Verfügbarkeit prüfen

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain

British journal of cancer, 1991-05, Vol.63 (5), p.670-674

1991

Link zum Volltext

Verfügbarkeit prüfen

Targeting of bladder cancer with monoclonal antibody NCRC48—a possible approach for intravesical therapy

British Journal of Urology, 1995-07, Vol.76 (1), p.81-86

1995

Link zum Volltext

Verfügbarkeit prüfen

Tissue retention of indium-labelled antibodies

European Journal of Nuclear Medicine, 1995-09, Vol.22 (9), p.1078-1079

1995

Link zum Volltext

Verfügbarkeit prüfen

The influence of syngeneic anti‐idiotypic antibody on the biodistribution of an anti‐tumour monoclonal antibody in balb/c mice

International journal of cancer, 1989-01, Vol.43 (1), p.147-151

1989

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents

Cancer research (Chicago, Ill.), 1987-10, Vol.47 (20), p.5277

1987

Link zum Volltext

Verfügbarkeit prüfen

Capture of recombinant ricin A chain by a bispecific anti-RTA : anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice

Journal of cancer research and clinical oncology, 1992-05, Vol.118 (5), p.367-370

1992

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts

Cancer Immunology Immunotherapy, 1988-10, Vol.27 (3), p.267-271

1988

Link zum Volltext

Verfügbarkeit prüfen

Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice

Journal of cancer research and clinical oncology, 1992, Vol.119 (1), p.41-45

1992

Link zum Volltext

Verfügbarkeit prüfen

Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumor-associated antigens on the biodistribution of their target antibodies and their fragments

Journal of cancer research and clinical oncology, 1993-07, Vol.119 (7), p.408-414

1993

Link zum Volltext

Verfügbarkeit prüfen

The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours

British journal of surgery, 1984-06, Vol.71 (6), p.407-412

1984

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates

Cancer research (Chicago, Ill.), 1987-10, Vol.47 (19), p.5042-5046

1987

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and tumour localization of a methotrexate‐monoclonal‐antibody 791T/36 conjugate in nude mice with human tumour xenografts

International journal of cancer, 1988-06, Vol.41 (6), p.886-891

1988

Link zum Volltext

Verfügbarkeit prüfen

Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography

Cancer Immunology Immunotherapy, 1991-11, Vol.33 (6), p.359-366

1991

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine

Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates

Circulating antigen: Bad or good for immunoscintigraphy?

An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts

Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments

Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone

The Characteristics of Blood-Borne Radiolabels and the Effect of Anti-Mouse IgG Antibodies on Localization of Radiolabeled Monoclonal Antibody in Cancer Patients

Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations

Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope

Evaluation of monoclonal idiotypic-specific antibodies as clearing antibodies for enhancement of target localisation by tumour-specific monoclonal antibodies: diversity of effects in nude mice with human tumour xenografts

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate

Carrier Design: New Generation of Polycationic Branched Polypeptides Containing OH Groups with Prolonged Blood Survival and Diminished in Vitro Cytotoxicity

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain

Targeting of bladder cancer with monoclonal antibody NCRC48—a possible approach for intravesical therapy

Tissue retention of indium-labelled antibodies

The influence of syngeneic anti‐idiotypic antibody on the biodistribution of an anti‐tumour monoclonal antibody in balb/c mice

Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents

Capture of recombinant ricin A chain by a bispecific anti-RTA : anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice

Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts

Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice

Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumor-associated antigens on the biodistribution of their target antibodies and their fragments

The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours

Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates

Biodistribution and tumour localization of a methotrexate‐monoclonal‐antibody 791T/36 conjugate in nude mice with human tumour xenografts

Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography

Suchergebnisse filtern